Tilray Brands, Inc. has grown revenue 14% a year over three years and 11% a year over five. Revenue growth, 3-year annual rate: +14% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +11%, growth has picked up over the last three years. Years of annual history on file: 10, FY2016 to FY2026, as filed.

TLRYTilray Brands, Inc.

Healthcare

$3.60-79% 1Y

$3.60

$3.5752 weeks$21.00

Is it growing?

Good

Growing: revenue growing +16% year on year and operating margin widening (+258.2 points).

2 good, 1 without data

Revenue trend+16% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +11% a year.

Margin direction+258.2 points operating

Trailing-twelve-month operating margin, -9.6% now against -267.8% a year earlier.

All from SEC EDGAR, as of Aug 31, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TLRY growing?

Tilray Brands, Inc. has grown revenue 14% a year over three years and 11% a year over five.

+14%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +11%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2026, as filed

Details›